Trial: 202002046

ENGOT-ov50 / INNOVATE-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 200kHz) concomitant with weekly paclitaxel for the treatment of recurrent ovarian cancer

Phase

III (Cancer Control)

Principal Investigator

Thaker, Premal

Disease Site

Cervix; Corpus Uteri; Ovary

Learn more about this study at: clinicaltrials.gov